OptMyCare™ Raises $3 Million in Series A

by Kay Aloha Villamor in May 10th, 2024

OptMyCare™, a Dallas, TX-based clinically engineered AI platform specializing in healthcare and risk management, has raised $3 million in Series A funding, bringing its total raised to $4.5 million. 


The round was led by LiveOak Ventures of Austin, Texas, a venture capital firm making early-stage investments in technology and technology-driven services from pre-seed to Series B. LiveOak partners with exceptional Texas-based founders to build tech and tech-enabled service companies.  

OptMyCare™ Use of Funds 

The additional capital infusion will accelerate OptMyCare™'s customer acquisition plans, refine its technology, onboard key management personnel, and recruit experienced healthcare and technology leaders. 

About OptMyCare™ 

Founded in 2019 by Dr. Antony E. Pfaffle, MD, and Dr. Saravanan Balamuthusamy, MD, MPH, FASN, FASDIN, OptMyCare™ offers a scalable, secure, and cloud-based SaaS product that combines precision analytics with actionable risk stratification solutions for multiple chronic conditions. Leveraging clinically-engineered algorithms, the platform analyzes data from 55 chronic clinical diagnoses, associated procedures, and claims costs to facilitate rapid and accurate risk identification. These predictive and prescriptive solutions actively help risk bearers improve workflow, lowering the time and cost involved with this process. 

Funding Details 

Company: OptMyCare, Inc. 

Raised: $3.0M 

Round: Series A 

Funding Month: May 2024 

Lead Investors: LiveOak Ventures 

Additional Investors: 

Company Website: https://opt-mycare.com/ 

Software Category: Healthcare and Risk Management 

Source: https://www.prnewswire.com/news-releases/optmycare-secures-3-million-in-series-a-funding-from-investor-group-led-by-liveoak-ventures-302137662.html

Your cart